The results of the first approach to vascular normalization show that the inhibitory effect of angiostatin in suppressing the microvasculature and reducing its density cannot lead to an improvement in drug delivery to the tumor site in terms of both average drug exposure and its uniformity. This evidence concerns the gene PLG and neoplasm.